Human trials begin in fortnight, J&J works to ramp up production of affordable Covid vaccine: Top scientist

Johnson & Johnson is preparing the ground for the entry of a vaccine against Covid-19 and is expanding its manufacturing capacity to supply more than one billion doses through 2021 in a not-for-profit project aimed at the common person, says its top scientist.